Breaking News

Evotec, Yale Form Innovation Alliance

January 9, 2013

Aims to integrate discovery infrastructure to advance projects for development

Evotec and Yale University have entered into a strategic partnership to jointly assess and potentially pursue novel assays, screens and models, and in particular, exploratory drug targets and compounds in the areas of metabolic diseases, CNS, immunological diseases and cancer. The goal is to integrate Evotec's drug discovery infrastructure with highly innovative biology at Yale to mature individual projects to a stage where they can be commercialized.
Dr. Cord Dohrmann, chief scientific officer of Evotec, said, "We are very excited about this open innovation alliance with Yale. There is a tremendous wealth of scientific innovation at Yale that has the potential to be directly translated into first- and best-in-class drug candidates. Together we want to significantly accelerate this process by removing technical bottlenecks and focusing all efforts on bringing individual projects to highest industrial standards in preparation for development and commercialization partnerships with pharma companies."
"This agreement is a new collaboration model between academia and the pharma industry. It essentially gives all faculties at Yale the opportunity to directly translate new biological insights into top-notch drug discovery projects. Evotec is uniquely suited as a partner as they combine an extremely broad drug discovery platform with fast processes and proven commercialization skills," said Dr. Jon Soderstrom, managing director of Yale's Office of Cooperative Research.

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry